| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 11.4 | 12.3 | 12.3 |
| Other income | 0.1 | 0.1 | 0.1 |
| Total income | 11.5 | 12.4 | 12.4 |
| Profit before exceptional items & tax | 0.7 | 1.1 | 1.0 |
| Exceptional items | 0.5 | 0.0 | 0.0 |
| Profit before tax | 0.2 | 1.1 | 1.0 |
| Net profit | 0.1 | 0.7 | -3.4 |
| Operating margin | 1.7% | 8.9% | 8.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -85.70% |
|---|---|
| Revenue, year on year | -7.30% |
Source
Read the filing ↗
BSE results filing, NSE: GUJTERC. Figures extracted from the filing.
Gujarat Terce Laboratories Ltd: key numbers
- Share price
- ₹39.29
- Market cap
- ₹29.15 Cr
- Revenue (annual)
- ₹47.47 Cr
- Net profit (annual)
- ₹2.20 Cr
- P/E (TTM)
- 14.0×Sector 50.4×
- Promoter holding
- 40.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Terce Laboratories Ltd
All →
16:45 IST
BSE
Financial Results
Gujarat Terce Laboratories Q1 FY27 Results: Net Loss of ₹0.2 Cr
Gujarat Terce Laboratories Ltd reported revenue from operations of ₹9 Cr (-17.4% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
16:41 IST
BSE
Earnings Call
Gujarat Terce Laboratories Earnings Call: Key Takeaways
Gujarat Terce reports a challenging Q4 FY26 with an 8% revenue decline but a return to profitability (PAT 10.1L vs loss). Strategy focuses on brand equity and field productivity.